Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Monotherapy After Stenting in ACS (T-PASS)
NCT03797651Unknown
- Sponsor
- Yonsei University
- Start
- Apr 2019
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Yonsei University. Primary endpoint: Net clinical benefit at 1 year. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03797651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797651.